Prognosis
J&J Vaccine Trial Has Enough Data to Analyze Soon: Fauci
This article is for subscribers only.
Johnson & Johnson has sufficient data from its late-stage Covid-19 vaccine trial to begin analysis soon, Anthony Fauci, the government’s top infectious disease doctor, said Thursday.
Fauci said in remarks at the White House that the company would have enough data on its vaccine to begin analysis in as soon as a week or two.